Retex Pharmaceuticals Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 3

Retex Pharmaceuticals General Information

Description

Developer of therapeutic medicines intended to cure disease. The company engages in developing novel medicines for chronic diseases by targeting ion channels and GPCRs, enabling doctors to cure patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 134 Coolidge Avenue
  • Watertown, MA 02472
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 134 Coolidge Avenue
  • Watertown, MA 02472
  • United States

Retex Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Retex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 15-Sep-2025 Completed Startup
1. Early Stage VC 01-Feb-2023 Completed Startup
To view Retex Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Retex Pharmaceuticals Patents

Retex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026035773-A1 Vasopressin receptor 2 modulators and methods of use thereof Pending 06-Aug-2024

Retex Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Retex Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
LongRiver Investments Venture Capital Minority
3E Bioventures Capital Venture Capital Minority
Liquidmetal Ventures Venture Capital Minority
To view Retex Pharmaceuticals’s complete investors history, request access »

Retex Pharmaceuticals FAQs

  • When was Retex Pharmaceuticals founded?

    Retex Pharmaceuticals was founded in 2022.

  • Where is Retex Pharmaceuticals headquartered?

    Retex Pharmaceuticals is headquartered in Watertown, MA.

  • What is the size of Retex Pharmaceuticals?

    Retex Pharmaceuticals has 3 total employees.

  • What industry is Retex Pharmaceuticals in?

    Retex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Retex Pharmaceuticals a private or public company?

    Retex Pharmaceuticals is a Private company.

  • What is Retex Pharmaceuticals’s current revenue?

    The current revenue for Retex Pharmaceuticals is .

  • How much funding has Retex Pharmaceuticals raised over time?

    Retex Pharmaceuticals has raised $2M.

  • Who are Retex Pharmaceuticals’s investors?

    LongRiver Investments, 3E Bioventures Capital, and Liquidmetal Ventures have invested in Retex Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process